Downstream Processing Market Report 2026 Market Outlook Supported By A Forecast 13.5% CAGR

The downstream processing market is on the brink of significant expansion as the biopharmaceutical sector continues to advance. With increasing demand for efficient purification methods and innovative technologies, this market is set to experience remarkable growth in the coming years. Let's delve into the current market size, key players, driving factors, emerging trends, and important segments shaping this evolving industry.

Projection of Market Size and Growth in the Downstream Processing Market
The downstream processing market is anticipated to grow rapidly, reaching a valuation of $66.59 billion by 2030. This impressive expansion corresponds to a compound annual growth rate (CAGR) of 13.5%. Factors contributing to this upward trend include the rising production of biosimilars, growth in vaccine manufacturing, increased automation in bioprocessing, demand for cost-effective purification techniques, and expansion in Contract Development and Manufacturing Organization (CDMO) capacities. Notable market trends forecasted through this period involve heightened demand for biologic drug purification, wider adoption of continuous processing models, increased use of single-use technologies, growth in chromatography-based purification processes, and a strong focus on optimizing process yields.

The downstream processing market size has grown rapidly in recent years. It will grow from $35.45 billion in 2025 to $40.2 billion in 2026 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to biologics market growth, monoclonal antibody production, biopharmaceutical investment, traditional batch processing dominance, regulatory quality standards.

Download a free sample of the downstream processing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10155&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Key Factors Encouraging Growth in the Downstream Processing Market
A growing biosimilar production pipeline is driving demand for more efficient downstream processing techniques. As biosimilars gain traction for their cost advantages and therapeutics, manufacturers require reliable and scalable purification systems to meet quality and regulatory standards.
Additionally, expanding vaccine manufacturing efforts worldwide are pushing the need for advanced downstream solutions. Efficient purification steps are critical to vaccine safety and efficacy, which propels investments in innovative processing technologies.

Prominent Companies Leading the Downstream Processing Market
The downstream processing market features several established players including Sartorius AG, General Electric Company, Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Repligen Corporation, Lonza Group Ltd., Eppendorf AG, Corning Corporation, Ashai Kasei Corporation, Finesse Solutions Inc., MilliporeSigma, Pall Corporation, Bio-Rad Laboratories, Charles River Laboratories International Inc., Waters Corporation, Becton dic*kinson and Company (BD), Entegris Inc., Novasep, Avantor Sciences, Tecan Group, Agilent Technologies, Boehringer Ingelheim International GmbH, Ahlstrom-Munksjö Oyj, Grifols S.A., and GenScript Biotech Corporation.
In a notable development, January 2023 saw Astea Bio Separations, a UK-based bioseparation technology provider, acquire Delta Precision Ltd. Though financial details were undisclosed, this acquisition aims to bolster Astea's portfolio by incorporating Delta Precision's advanced chromatography column technologies, which are vital for protein purification, vaccine production, and drug development processes.

View the full downstream processing market report:
https://www.thebusinessresearchcompany.com/report/downstream-processing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Innovations Fueling the Future of the Downstream Processing Market
Leading companies are actively pursuing innovative solutions to enhance process efficiency and monitoring. One such advancement is the development of flow cells-devices that enable continuous liquid sample analysis, providing real-time bioprocess condition monitoring and control during downstream operations.
For example, in October 2023, Germany's SCHOTT AG introduced ViewCell, a flow cell component designed to deliver safe, continuous process control in biopharmaceutical manufacturing. ViewCell improves flexibility in monitoring, allowing precise regulation of critical parameters and boosting the efficiency and reliability of downstream processes.

Breakdown of Major Market Segments in Downstream Processing
This market is segmented by product type, including centrifuges, dryers, chromatography systems, filters, evaporators, and other related equipment.
It is also categorized by technique into purification techniques, solid-liquid separation, and clarification or concentration processes.
Applications encompass monoclonal antibody production, vaccine production, insulin production, immunoglobulin production, erythropoietin production, and various other uses.
Further detailed subsegments cover centrifuges (analytical and preparative), dryers (spray, freeze, and fluidized bed), chromatography systems (liquid, gas, and affinity types), filters (membrane, depth, and cartridge), evaporators (thin film, forced circulation, falling film), and other products such as mixers, precipitation systems, and storage tanks.

This comprehensive segmentation offers valuable insights into the components driving downstream processing market growth and highlights areas of innovation and investment.

What's included in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.